Guardant Health Stock
Bio-tech company focus on oncology
Sign up today and learn more about Guardant Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Guardant Health Stock
Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.
Investors
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Sequoia Capital
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Lightspeed Venture Partners
Snap, OYO, AppDynamics, TripActions, Faire, Affirm, Netskope, LivingSocial, Weee!, ThoughtSpot
Khosla Ventures
Instacart, Stripe, DoorDash, Impossible Foods, Palantir Technologies, Commonwealth Fusion, View, Zenefits, Eat Just, Opendoor
Funding History
April 2013 | $9.2M |
---|---|
April 2014 | $32.6M |
December 2014 | $56.0M |
December 2015 | $83.9M |
May 2017 | $334M |
Management
Chief Executive Officer
Helmy Eltoukhy
Chief Financial Officer
Derek Bertocci
Chief Legal Officer
Michael Wiley
Chief Medical Officer
Richard Lanman
COO & President
AmirAli Talasaz
VP of Marketing
Sandra Finley
Head of Sales
Stanley Welle
VP of Bioinformatics
Darya Chudova
Vice President, Pharma Business Development
Daniel Simon
Press
Fairfield Current - Nov, 6 2018
Guardant Health (NASDAQ:GH) Coverage Initiated by Analysts at Bank of AmericaNasdaq - Nov, 1 2018
October's winners & losers: Growth IPOs still fly highNasdaq Place (press release) - Oct, 31 2018
Guardant Health, Inc. (GH) moves -0.38% below SMA-50TechCrunch - Oct, 28 2018
These 14 startups — endorsed by the seed-stage investment firm Pear — just hit the fundraising trailMarketWatch - Sep, 6 2018
Cancer blood-testing company Guardant Health files for IPO